Kinetics, Biodistribution, Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit, in Healthy Male Volunteers and Patients With Limited Recurrent Prostate Cancer
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- 10 Aug 2017 Status changed from not yet recruiting to withdrawn prior to enrolment as the ethics committee did not approved the start of the study
- 10 Jul 2017 Planned initiation date changed from 30 Jun 2017 to 30 Jul 2017.
- 20 Jun 2017 Planned initiation date changed from 16 Jun 2017 to 30 Jun 2017.